Grandeur Peak Global Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-239
Closed -$134K 98
2025
Q4
$134K Sell
239
-2,196
-90% -$1.25M 0.02% 101
2025
Q3
$1.25M Sell
2,435
-16,191
-87% -$7.07M 0.17% 75
2025
Q2
$5.85M Buy
18,626
+338
+2% +$101K 0.7% 42
2025
Q1
$5.57M Sell
18,288
-9,977
-35% -$3.36M 0.62% 42
2024
Q4
$9.39M Buy
28,265
+165
+0.6% +$56K 0.83% 31
2024
Q3
$9.38M Buy
28,100
+6,849
+32% +$2.6M 0.78% 38
2024
Q2
$8.75M Sell
21,251
-7,260
-25% -$2.88M 0.7% 44
2024
Q1
$11.5M Sell
28,511
-8,613
-23% -$3.03M 0.92% 32
2023
Q4
$11.4M Sell
37,124
-8,024
-18% -$2.17M 0.8% 28
2023
Q3
$10.9M Sell
45,148
-44,358
-50% -$11.3M 0.82% 24
2023
Q2
$21.5M Buy
89,506
+1,260
+1% +$262K 1.47% 17
2023
Q1
$16.6M Buy
88,246
+3,345
+4% +$692K 1.01% 24
2022
Q4
$18M Sell
84,901
-63,215
-43% -$12.6M 1.07% 24
2022
Q3
$23.3M Buy
148,116
+5,441
+4% +$868K 1.43% 19
2022
Q2
$21.4M Buy
142,675
+20,879
+17% +$3.02M 1.33% 21
2022
Q1
$19.9M Buy
121,796
+86,258
+243% +$14.2M 0.94% 26
2021
Q4
$7.73M Sell
35,538
-1,529
-4% -$320K 0.35% 52
2021
Q3
$7.02M Buy
37,067
+2,000
+6% +$365K 0.33% 53
2021
Q2
$6.19M Buy
35,067
+2,700
+8% +$466K 0.3% 59
2021
Q1
$5.31M Buy
32,367
+3,100
+11% +$474K 0.29% 54
2020
Q4
$4.07M Buy
29,267
+10,300
+54% +$1.3M 0.23% 60
2020
Q3
$2.12M Buy
18,967
+1,817
+11% +$210K 0.14% 77
2020
Q2
$1.59M Buy
17,150
+14,200
+481% +$1.21M 0.12% 79
2020
Q1
$216K Buy
+2,950
New +$256K 0.02% 106

Other funds holding MEDP

Grandeur Peak Global Advisors's MEDP Position: Q1 2026 in Review

Grandeur Peak Global Advisors sold out of Medpace (MEDP) in Q1 2026, closing a stake of 239 shares — an estimated $134K sold.

Grandeur Peak Global Advisors first reported a position in MEDP in Q1 2020 and held it in 24 quarters. The position peaked at $23.3M in Q3 2022. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Grandeur Peak Global Advisors reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 239 Medpace shares in Q1 2026, an estimated $134K.
  • Grandeur Peak Global Advisors first reported a position in Medpace in Q1 2020 and held it in 24 quarters.
  • Grandeur Peak Global Advisors's Medpace position peaked at $23.3M in Q3 2022.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Grandeur Peak Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.